Press Releases Archive - Clinical Trials Arena https://www.clinicaltrialsarena.com/pressreleases/ Hard data and deep insights on clinical trials strategy & operations Wed, 23 Oct 2024 08:26:07 +0000 en-US hourly 1 https://wordpress.org/?v=6.6.2 https://www.clinicaltrialsarena.com/wp-content/uploads/sites/22/2022/01/cropped-Clinical-Trials-Arena-32x32.png Press Releases Archive - Clinical Trials Arena https://www.clinicaltrialsarena.com/pressreleases/ 32 32 Biopharmaceutical Manufacturer Adopts Bespoke Thermal Packaging Solution with Topa Thermal https://www.clinicaltrialsarena.com/contractors/clinical-trial-logistics-and-supplies/topa-thermal/pressreleases/bespoke-thermal-packaging-solution/ Wed, 23 Oct 2024 08:26:07 +0000 https://www.clinicaltrialsarena.com/?post_type=pressreleases&p=219448 A leading biopharmaceutical manufacturer transitioned from pre-qualified thermal packaging to a bespoke solution for the distribution of its Phase III temperature-sensitive clinical trial products. This strategic shift, in collaboration with Topa Thermal, significantly optimised their logistics process, reduced product damage risks, and lowered operating costs.

The post Biopharmaceutical Manufacturer Adopts Bespoke Thermal Packaging Solution with Topa Thermal appeared first on Clinical Trials Arena.

]]> A leading biopharmaceutical manufacturer transitioned from pre-qualified thermal packaging to a bespoke solution for the distribution of its Phase III temperature-sensitive clinical trial products. This strategic shift, in collaboration with Topa Thermal, significantly optimised their logistics process, reduced product damage risks, and lowered operating costs.

The post Biopharmaceutical Manufacturer Adopts Bespoke Thermal Packaging Solution with Topa Thermal appeared first on Clinical Trials Arena.

]]> SOM Biotech Announces the Presentation of the Phase IIb Study Results in Huntington’s Chorea Patients at the HDG Conference in Cincinnati https://www.clinicaltrialsarena.com/contractors/software-technology/som-biotech/pressreleases/study-results-huntingtons-chorea/ Tue, 15 Oct 2024 10:05:22 +0000 https://www.clinicaltrialsarena.com/?post_type=pressreleases&p=218863 SOM Biotech, a clinical-stage drug discovery and development company based on a unique proprietary artificial intelligence platform, announces the presentation of the top-line results of a Phase IIb study with SOM3355 compound on Huntington's disease patients with chorea at the Annual Meeting of the Huntington Study Group (HSG) in Cincinnati, Ohio, on 7-9 November 2024 at the session 'Contemporary Trials and Next Steps'.

The post SOM Biotech Announces the Presentation of the Phase IIb Study Results in Huntington’s Chorea Patients at the HDG Conference in Cincinnati appeared first on Clinical Trials Arena.

]]> SOM Biotech, a clinical-stage drug discovery and development company based on a unique proprietary artificial intelligence platform, announces the presentation of the top-line results of a Phase IIb study with SOM3355 compound on Huntington's disease patients with chorea at the Annual Meeting of the Huntington Study Group (HSG) in Cincinnati, Ohio, on 7-9 November 2024 at the session 'Contemporary Trials and Next Steps'.

The post SOM Biotech Announces the Presentation of the Phase IIb Study Results in Huntington’s Chorea Patients at the HDG Conference in Cincinnati appeared first on Clinical Trials Arena.

]]> “African scientists are ready to take the lead in developing an effective HIV vaccine”: Interview with Professor Glenda Gray https://www.clinicaltrialsarena.com/contractors/data-management/bioinformatico/pressreleases/interview-professor-glenda-gray/ Fri, 11 Oct 2024 10:05:14 +0000 https://www.clinicaltrialsarena.com/?post_type=pressreleases&p=218695 Professor Glenda Gray, former president and CEO of the South African Medical Research Council, is the Principal Investigator of the BRILLIANT Consortium, a USAID-funded cooperative agreement dedicated to accelerating HIV vaccine discovery and development in Africa. She was one of TIME Magazine’s most 100 influential people in the world, and she has also been listed by Forbes as one of Africa’s 50 most powerful women. Professor Gray co-founded and directed the renowned Perinatal HIV Research Unit at the Chris Hani Baragwanath Hospital and is the Co-PI of the NIH-funded HIV Vaccine Trials Network (HVTN).

The post “African scientists are ready to take the lead in developing an effective HIV vaccine”: Interview with Professor Glenda Gray appeared first on Clinical Trials Arena.

]]> Professor Glenda Gray, former president and CEO of the South African Medical Research Council, is the Principal Investigator of the BRILLIANT Consortium, a USAID-funded cooperative agreement dedicated to accelerating HIV vaccine discovery and development in Africa. She was one of TIME Magazine’s most 100 influential people in the world, and she has also been listed by Forbes as one of Africa’s 50 most powerful women. Professor Gray co-founded and directed the renowned Perinatal HIV Research Unit at the Chris Hani Baragwanath Hospital and is the Co-PI of the NIH-funded HIV Vaccine Trials Network (HVTN).

The post “African scientists are ready to take the lead in developing an effective HIV vaccine”: Interview with Professor Glenda Gray appeared first on Clinical Trials Arena.

]]> SubjectWell Announces Strategic Acquisition of Trials24 to Expand Global Patient Recruitment Capabilities https://www.clinicaltrialsarena.com/contractors/clinical-trial-patient-recruitment/trials24/pressreleases/subjectwell-acquisition-trials24/ Tue, 17 Sep 2024 11:06:49 +0000 https://www.clinicaltrialsarena.com/?post_type=pressreleases&p=216792 SubjectWell, provider of the most accurate, diverse, predictable and patient-centric patient recruitment platform, is pleased to announce its acquisition of Trials24, a renowned provider of global digital patient recruitment solutions. This strategic acquisition will enhance SubjectWell's ability to connect patients to transformative healthcare across all geographies.

The post SubjectWell Announces Strategic Acquisition of Trials24 to Expand Global Patient Recruitment Capabilities appeared first on Clinical Trials Arena.

]]> SubjectWell, provider of the most accurate, diverse, predictable and patient-centric patient recruitment platform, is pleased to announce its acquisition of Trials24, a renowned provider of global digital patient recruitment solutions. This strategic acquisition will enhance SubjectWell's ability to connect patients to transformative healthcare across all geographies.

The post SubjectWell Announces Strategic Acquisition of Trials24 to Expand Global Patient Recruitment Capabilities appeared first on Clinical Trials Arena.

]]> Sustainability vs Suitability: Challenging Conventional Thinking in Temperature-Controlled Packaging Design https://www.clinicaltrialsarena.com/contractors/clinical-trial-logistics-and-supplies/topa-thermal/pressreleases/sustainability-vs-suitability/ Mon, 16 Sep 2024 13:41:52 +0000 https://www.clinicaltrialsarena.com/?post_type=pressreleases&p=215461 Topa Thermal is pleased to announce that Maarten Kleverlaan, Topa Thermal’s Technical Solutions Manager, will be a featured speaker at the International Safe Transit Association (ISTA) European Packaging Symposium, taking place on October 8-9 in Frankfurt, Germany.

The post Sustainability vs Suitability: Challenging Conventional Thinking in Temperature-Controlled Packaging Design appeared first on Clinical Trials Arena.

]]> Topa Thermal is pleased to announce that Maarten Kleverlaan, Topa Thermal’s Technical Solutions Manager, will be a featured speaker at the International Safe Transit Association (ISTA) European Packaging Symposium, taking place on October 8-9 in Frankfurt, Germany.

The post Sustainability vs Suitability: Challenging Conventional Thinking in Temperature-Controlled Packaging Design appeared first on Clinical Trials Arena.

]]> Topa Thermal Unveils Quick-Tips Video Series on Cold Chain Management https://www.clinicaltrialsarena.com/contractors/clinical-trial-logistics-and-supplies/topa-thermal/pressreleases/topa-thermal-unveils-video-series/ Wed, 28 Aug 2024 13:16:23 +0000 https://www.clinicaltrialsarena.com/?post_type=pressreleases&p=215138 Topa Thermal, a leader in temperature-controlled packaging solutions, is excited to announce the release of a new series of 60-second cold chain videos. These informative and engaging videos are fronted by Topa Thermal’s respected Product Director Richard Harrop.

The post Topa Thermal Unveils Quick-Tips Video Series on Cold Chain Management appeared first on Clinical Trials Arena.

]]> Topa Thermal, a leader in temperature-controlled packaging solutions, is excited to announce the release of a new series of 60-second cold chain videos. These informative and engaging videos are fronted by Topa Thermal’s respected Product Director Richard Harrop.

The post Topa Thermal Unveils Quick-Tips Video Series on Cold Chain Management appeared first on Clinical Trials Arena.

]]> First UK Showing of °Connex ECO: Zero Waste Thermal Packaging https://www.clinicaltrialsarena.com/contractors/clinical-trial-logistics-and-supplies/topa-thermal/pressreleases/connex-eco-thermal-packaging/ Wed, 31 Jul 2024 10:57:26 +0000 https://www.clinicaltrialsarena.com/?post_type=pressreleases&p=213069 Topa Thermal, a leading innovator in thermal packaging and part of the industrial packaging group Topa, proudly showcased °Connex ECO at the 2024 annual Outsourcing in Clinical Trials UK & Ireland event, held last month at the Hilton, Park Lane London. This novel packaging product is set to transform the transportation of temperature-sensitive clinical trial products with its sustainable and recyclable design.

The post First UK Showing of °Connex ECO: Zero Waste Thermal Packaging appeared first on Clinical Trials Arena.

]]> Topa Thermal, a leading innovator in thermal packaging and part of the industrial packaging group Topa, proudly showcased °Connex ECO at the 2024 annual Outsourcing in Clinical Trials UK & Ireland event, held last month at the Hilton, Park Lane London. This novel packaging product is set to transform the transportation of temperature-sensitive clinical trial products with its sustainable and recyclable design.

The post First UK Showing of °Connex ECO: Zero Waste Thermal Packaging appeared first on Clinical Trials Arena.

]]> SOM Biotech Announces the Database Lock of Its Phase IIb Study with SOM3355 in Huntington’s Chorea Patients and Looks for Top-Line Results in August https://www.clinicaltrialsarena.com/contractors/software-technology/som-biotech/pressreleases/database-lock-phase-2b-study/ Thu, 25 Jul 2024 09:22:23 +0000 https://www.clinicaltrialsarena.com/?post_type=pressreleases&p=212512 SOM Biotech, a clinical-stage drug discovery and development company based on a unique proprietary artificial intelligence (AI) platform, is pleased to announce the database lock of the Phase IIb study SOMCT03 with SOM3355 for the treatment of chorea in Huntington’s disease (HD).

The post SOM Biotech Announces the Database Lock of Its Phase IIb Study with SOM3355 in Huntington’s Chorea Patients and Looks for Top-Line Results in August appeared first on Clinical Trials Arena.

]]> SOM Biotech, a clinical-stage drug discovery and development company based on a unique proprietary artificial intelligence (AI) platform, is pleased to announce the database lock of the Phase IIb study SOMCT03 with SOM3355 for the treatment of chorea in Huntington’s disease (HD).

The post SOM Biotech Announces the Database Lock of Its Phase IIb Study with SOM3355 in Huntington’s Chorea Patients and Looks for Top-Line Results in August appeared first on Clinical Trials Arena.

]]> IKA Launches Eco-Friendly Cooled Incubator https://www.clinicaltrialsarena.com/contractors/lab-equipment/ika-werke/pressreleases/eco-friendly-cooled-incubator/ Tue, 16 Jul 2024 09:13:54 +0000 https://www.clinicaltrialsarena.com/contractors/data//pressreleases/eco-friendly-cooled-incubator/ IKA-Werke is expanding its portfolio of temperature chambers with an environmentally friendly and resource-saving cooled incubator. The new INC 125 FC digital complements the existing models, the classic INC 125 F digital incubator and the INC 125 FS digital incubator shaker with its patented removable shaking platform. All devices in the series are ideal for applications in the life sciences: for microbiological tests, stability studies or cell cultivation.

The post IKA Launches Eco-Friendly Cooled Incubator appeared first on Clinical Trials Arena.

]]> IKA-Werke is expanding its portfolio of temperature chambers with an environmentally friendly and resource-saving cooled incubator. The new INC 125 FC digital complements the existing models, the classic INC 125 F digital incubator and the INC 125 FS digital incubator shaker with its patented removable shaking platform. All devices in the series are ideal for applications in the life sciences: for microbiological tests, stability studies or cell cultivation.

The post IKA Launches Eco-Friendly Cooled Incubator appeared first on Clinical Trials Arena.

]]> Navigating Neurology Trials: How Avance Clinical Achieved Success with TrialHub’s Precise Recruitment Rate Assessments https://www.clinicaltrialsarena.com/contractors/ps-ai/trialhub/pressreleases/navigating-neurology-trials/ Tue, 18 Jun 2024 14:31:27 +0000 https://www.clinicaltrialsarena.com/?post_type=pressreleases&p=208113 This case study details the strategic collaboration between Avance Clinical and TrialHub to secure a number of Phase I/II clinical trials in neurology sub-specialties. Avance Clinical leveraged TrialHub’s advanced data capabilities to deliver a proposal with unparalleled depth and specificity, resulting in not only being awarded the opportunity to partner, but also earning an additional study from the impressed client. The success showcases the critical role of precise, data-driven feasibility assessments in modern drug development.

The post Navigating Neurology Trials: How Avance Clinical Achieved Success with TrialHub’s Precise Recruitment Rate Assessments appeared first on Clinical Trials Arena.

]]> This case study details the strategic collaboration between Avance Clinical and TrialHub to secure a number of Phase I/II clinical trials in neurology sub-specialties. Avance Clinical leveraged TrialHub’s advanced data capabilities to deliver a proposal with unparalleled depth and specificity, resulting in not only being awarded the opportunity to partner, but also earning an additional study from the impressed client. The success showcases the critical role of precise, data-driven feasibility assessments in modern drug development.

The post Navigating Neurology Trials: How Avance Clinical Achieved Success with TrialHub’s Precise Recruitment Rate Assessments appeared first on Clinical Trials Arena.

]]>